The
C-terminal tail of G-protein-coupled receptors (GPCR) contain
important regulatory sites that enable interaction with intracellular
signaling effectors. Here we examine the relative contribution of
the C-tail serine/threonine phosphorylation sites (Ser383–385, Ser387–Thr392) and the helix-8 palmitoylation
site (Cys361) in signaling regulation downstream of the
proteolytically activated GPCR, PAR2. We examined Gαq/11-coupled calcium signaling, β-arrestin-1/-2 recruitment, and
MAPK activation (p44/42 phosphorylation) by wild-type and mutant receptors
expressed in a CRISPR/Cas9 PAR2-knockout HEK-293 cell background with
both peptide stimulation of the receptor (SLIGRL-NH2) as
well as activation with its endogenous trypsin revealed a tethered
ligand. We find that alanine substitution of the membrane proximal
serine residues (Ser383–385Ala) had no effect on
SLIGRL-NH2- or trypsin-stimulated β-arrestin recruitment.
In contrast, alanine substitutions in the Ser387–Thr392 cluster resulted in a large (∼50%) decrease in β-arrestin-1/-2
recruitment triggered by the activating peptide, SLIGRL-NH2, but was without an effect on trypsin-activated β-arrestin-1/-2
recruitment. Additionally, we find that alanine substitution of the
helix-8 cysteine residue (Cys361Ala) led to a large decrease
in both Gαq/11 coupling and β-arrestin-1/-2
recruitment to PAR2. Furthermore, we show that Gαq/11 inhibition with YM254890, inhibited ERK phosphorylation by PAR2
agonists, while genetic deletion of β-arrestin-1/-2 by CRISPR/Cas9
enhanced MAPK activation. Knockout of β-arrestins also enhanced
Gαq/11-mediated calcium signaling. In line with these
findings, a C-tail serine/threonine mutant that has decreased β-arrestin
recruitment also showed enhanced ERK activation. Thus, our studies
point to multiple mechanisms that regulate β-arrestin interaction
with PAR2 and highlight differences in regulation of tethered-ligand-
and peptide-mediated activation of this receptor.